Jenna Sztorc

Roswell Park Comprehensive Cancer Center

Papers

2

Total Citations

67

H-Index

2

About

Dr. Jenna Sztorc is a leading urologic oncologist whose research focuses on improving surgical outcomes and prognostic accuracy for patients with bladder cancer, particularly through the advancement of robot-assisted surgical techniques. Her work has been instrumental in refining the perioperative management of patients undergoing robot-assisted radical cystectomy (RARC). In her highly cited 2014 study (50 citations), Dr. Sztorc identified key predictors and outcomes of hospital readmission within 90 days following RARC, providing critical insights for reducing postoperative complications and enhancing patient recovery pathways. She has also made significant contributions to risk stratification, leading a 2013 study that externally validated preoperative and postoperative nomograms for predicting cancer-specific survival, overall survival, and recurrence after RARC for urothelial carcinoma. This work helps clinicians more accurately counsel patients and tailor follow-up care. By combining rigorous outcomes analysis with a focus on minimally invasive surgery, Dr. Sztorc has helped shape evidence-based standards in urologic oncology, directly impacting clinical decision-making and long-term patient prognosis.

Research Focus

Key Achievements

2
H-Index
2
Papers
67
Total Citations
34
Avg Citations/Paper
🏆 Most Cited Paper
Readmission After Robot-assisted Radical Cystectomy: Outcomes and Predictors at 90-Day Follow-up
50 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Roswell Park Comprehensive Cancer Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago